Germing U - Search Results

1

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.

Kuendgen A, Müller-Thomas C, Lauseker M, Haferlach T, Urbaniak P, Schroeder T, Brings C, Wulfert M, Meggendorfer M, Hildebrandt B, Betz B, Royer-Pokora B, Gattermann N, Haas R, Germing U, Götze KS. Kuendgen A, et al. Among authors: germing u. Oncotarget. 2018 Jun 12;9(45):27882-27894. doi: 10.18632/oncotarget.25328. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963245 Free PMC article. Review.

2

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

3

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

4

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

5

Serum deoxythymidine kinase in myelodysplastic syndromes.

Aul C, Gattermann N, Germing U, Winkelmann M, Heyll A, Runde V, Schneider W. Aul C, et al. Among authors: germing u. Cancer. 1994 Jan 15;73(2):322-7. doi: 10.1002/1097-0142(19940115)73:2<322::aid-cncr2820730215>3.0.co;2-e. Cancer. 1994. PMID: 8293395

6

Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia.

Aul C, Gattermann N, Germing U, Südhoff T, Hollmig KA, Heyll A. Aul C, et al. Among authors: germing u. Leuk Res. 1997 Mar;21(3):249-53. doi: 10.1016/s0145-2126(96)00117-8. Leuk Res. 1997. PMID: 9111170

7

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: germing u. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

8

Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.

Meckenstock G, Aul C, Hildebrandt B, Heyll A, Germing U, Wehmeier A, Giagounidis A, Suedhoff T, Burk M, Soehngen D, Schneider W. Meckenstock G, et al. Among authors: germing u. Leuk Lymphoma. 1998 May;29(5-6):523-31. doi: 10.3109/10428199809050912. Leuk Lymphoma. 1998. PMID: 9643566

9

Problems in the classification of CMML--dysplastic versus proliferative type.

Germing U, Gattermann N, Minning H, Heyll A, Aul C. Germing U, et al. Leuk Res. 1998 Oct;22(10):871-8. doi: 10.1016/s0145-2126(97)00192-6. Leuk Res. 1998. PMID: 9766745

10

[Role of aggressive treatment strategies for myelodysplastic syndromes].

Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Praxis (Bern 1994). 1999 Mar 4;88(10):431-8. Praxis (Bern 1994). 1999. PMID: 10199215 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters